Purpose: Despite the compelling scientific and clinical data supporting the use of early oral nutrition after major gastrointestinal surgery, traditional bowel rest and intravenous nutrition for several postoperative days is still being used widely after gastric cancer surgery. Materials and Methods: A phase II study was carried out to evaluate the feasibility and safety of postoperative early oral intake (water intake on postoperative days (POD) 1-2, and soft diet on POD 3) after a gastrectomy. The primary outcome was morbidity within 30 postoperative days, which was targeted at <25% based on pilot study data. Results: The study subjects were 90 males and 42 females with a mean age 61.5 years. One hundred and four (79%) and 28 (21%) patients underwent a distal and total gastrectomy, respectively. The postoperative morbidity rate was within the targeted range (15.2%, 95% CI, 10.0~22.3%), and there was no hospital mortality. Of the 132 patients, 117 (89%) successfully completed a postoperative early oral intake regimen without deviation; deviation in 10 (8%) due to gastrointestinal symptoms and in five (4%) due to the management of postoperative complications. The mean times to water intake and a soft diet were 1.0±0.2 and 3.2±0.7 days, respectively, and the mean hospital stay was 10.0±6.1 days. Conclusions: Postoperative early oral intake after a gastrectomy is feasible and safe, and can be adopted as a standard perioperative care after a gastrectomy. Nevertheless, further clinical trials will be needed to evaluate the benefits of early oral nutrition after upper gastrointestinal surgery.
However, many surgeons still adhere to 'nil-by-mouth' during the early postoperative period after upper GI surgery and prefer enteral tube feeding distal to a new anastomosis for enteral nutritional support.
The major factors used to justify the traditional practice of oral intake restriction after upper GI surgeries are a fear of anastomosis dehiscence and postoperative ileus. However, this rationale of restricted oral nutrition is not evidence-based. A systemic review of early oral nutrition after upper GI surgery showed that no high quality trial has been conducted to address the topic of early oral This is an openaccess article distributed under the terms of the Creative Commons Attribution NonCommercial License (http://creativecommons.org/ licenses/bync/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The lack of comprehensive evidence regarding best clinical practice for perioperative care after gastrectomy has led to a lack of uniformity of several postoperative routines between countries and institutions. According to a survey on postoperative practice after gastrectomy in five Northern European countries, the majority of centers still adopt conservative nasogastric tube and 'nil-by-mouth' regimens for several days after gastrectomy. (9) In Japan, the socalled 'conventional fixed diet regimen' which includes the restriction of oral intake for the first 3~4 postoperative days is prevalent among institutions.(10) Furthermore, despite the current practice of postoperative early oral nutrition after colorectal and gynecologic surgery, relatively few studies have evaluated the feasibility and safety of early oral intake after gastric surgery. Accordingly, in this study, we evaluated the feasibility and safety of perioperative care adopting postoperative early oral intake in patients that had undergone elective gastrectomy for gastric carcinoma.
Materials and Methods

Study design and sample size
This study was designed as a phase 2 trial aimed at evaluating the feasibility of early oral intake after gastrectomy. Inclusion criteria were; histologically proven gastric adenocarcinoma, elective gastrectomy (distal or total) either via an open or laparoscopic approach, an age of ＜80 years, adequate organ function, no history of preoperative chemotherapy or radiotherapy, and the provision of written informed consent. Exclusion criteria were; an operation under emergency conditions (e.g., a gastric outlet obstruction per- No routine pro-motility or anti-emesis agent was used. Gradual compression stockings or an intermittent pneumatic compression device was used for venous thrombosis prophylaxis in all patients.
Patients were encouraged to ambulate actively from POD 1. Hospital discharge was targeted on POD 8, and objective discharge criteria were used to make decisions regarding discharge, namely; no sign of a postoperative complication, an ability to ambulate without assistance, tolerable pain on oral analgesia, able to take more than 70% of a given meal, and a willingness to go home.
Outcome measures
The primary outcome was postoperative morbidity, and the secondary outcomes were hospital course criteria, such as, compliance with early oral intake, nausea and vomiting, time to soft diet, onset of flatus, postoperative mortality, and hospital stay. The following postoperative complications were predefined and prospectively measured; abdominal bleeding, luminal bleeding, abdominal infection, pancreatic fistula, pancreatitis, anastomosis leakage, anastomosis stricture, ileus, duodenal stump leakage, and wound infection. Other complications were recorded as appropriate. Hospital mortality was defined as postoperative death for any cause within 30 postoperative days, or death within the hospitalization period.
Late complications, such as, dumping, diarrhea, anemia, and quality of life issues were not included in this study.
Statistical analyses
Statistical analyses were performed using the chi-square test or the independent t-test as appropriate. SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA) was used throughout, and statistical significance was accepted for P-value of less than 0.05.
Results
Clinicopathological characteristics
Between July 2009 and April 2010, 132 eligible patients with a diagnosis of gastric adenocarcinoma and who underwent elective gastrectomy were enrolled in this study. Table 1 
Surgical outcomes
The mean times to water intake and a soft diet were 1.0±0.2 and 3.2±0.7 days, respectively, and mean time to onset of first flatus was 2.6±1.0 days. Of the 132 patients, 100 (81.3%) patients were discharged from hospital on POD 8 after fulfilling the discharge criteria, and the mean hospital stay of all patients was 10.0 ±6.1 days (Table 2) . (Table 3 ).
Factors that may predict early oral intake failure after gastrectomy
A total of 15 (11.4%, 95% CI 7.0~17.9%) patients deviated from the postoperative early oral intake schedule with respect to water intake or soft diet commencement. To identify variables predictive of early postoperative oral intake failure, we compared successes and failures with respect to age, gender, BMI, comorbidity, ASA score, operation type, reconstruction method, combined organ resection, operating time, TNM stage, and postoperative morbidity.
However, no factor was found to be significantly associated with deviation from the early oral intake regimen, but postoperative morbidity (P=0.053) and TNM stage (P=0.053) showed a tendency to be associated with a deviation (Table 4) . (7) To the best of our knowledge, this study is the first phase 2 clinical trial to evaluate the feasibility and safety of early oral intake after gastrectomy. In this study, the primary outcome, postoperative morbidity rate, was within the targeted range (15.2%, 95% CI, 10.0~22.3%), and most patients (89%) were able to tolerate the early oral dietary schedule uneventfully. Therefore, our results indicate that early oral intake is feasible and safe after gastrectomy, as has been shown after other types of gastrointestinal surgery, and suggest that it could be adopted as a standard for perioperative care after gastric cancer surgery.
The practice of enteral tube feeding after esophagectomy or gastrectomy has been extensively documented in the literature. The extent of resection or type of operative approach might influence on the feasibility of early oral intake after gastric surgery.
However, in this study, no significant variables including patient and operation-related factors were found to predict a failure of postoperative early oral intake regimen. Theoretically, total gastrectomy is presumed to be less tolerable to early oral intake than distal gastrectomy due to no gastric reservoir after surgery. In the colcusion, this study shows that a perioperative care program incorporating the early institution of oral intake is feasible and safe after gastrectomy. Furthermore, early oral intake was not found to increase postoperative morbidity, and was tolerated by most patients without any adverse event. Accordingly, we suggest that early oral feeding could be adopted as a standardized perioperative care procedure after gastrectomy. Finally, further clinical trials are warranted to evaluate the benefits of early oral feeding on postoperative recovery, reducing postoperative complications, and on immunologic and nutritional functions.
